IL6 and breast cancer: We have also recently demonstrated that MPs secreted from both drug-resistant and drug-sensitive breast cancer cells polarize macrophages toward a pro-inflammatory state, producing increased IL-6 and TNF, and we hypothesize that this contributes to the establishment of a pre-metastatic niche (PMN) especially at secondary tumor sites (176).